(1R,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine is a chiral amine derivative featuring a tetrahydronaphthalene scaffold substituted with a 3,4-dichlorophenyl group. Its defined stereochemistry at the 1 and 4 positions makes it a valuable chiral building block in pharmaceutical synthesis. This compound is a key intermediate in the synthesis of Vilazodone, a medication approved for the treatment of major depressive disorder (MDD). Vilazodone acts as a selective serotonin reuptake inhibitor (SSRI) and a 5-HT1A receptor partial agonist. The specific stereochemistry of this intermediate is crucial for the biological activity of the final drug molecule, highlighting its role in constructing the pharmacologically active enantiomer. As a high-value chiral synthon, its production and application are primarily within the fine chemical and pharmaceutical manufacturing sectors, focusing on the development and production of central nervous system (CNS) active agents.